Global Argatroban Market Data Survey Report 2013-2025
SUMMARY
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
The global Argatroban market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
The global Argatroban market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
- Pfizer
- SANDOZ
- GlaxoSmithKline
- fresenius-kabi
- Eagle Pharmaceuticals
- Mitsubishi Tanabe Pharma
- Teva Pharmaceutical Industries
- WEST-WARD
- Heparin-induced thrombocytopenia (HIT)
- Percutaneous Coronary Intervention
- Cerebral arterial thrombosis
- Argatroban Powder
- Argatroban Injection
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
1 GLOBAL MARKET OVERVIEW
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 Pfizer
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 SANDOZ
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 GlaxoSmithKline
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 fresenius-kabi
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4.4 Recent Development
3.5 Eagle Pharmaceuticals
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5.4 Recent Development
3.6 Mitsubishi Tanabe Pharma
3.6.1 Company Information
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6.4 Recent Development
3.7 Teva Pharmaceutical Industries
3.7.1 Company Information
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 WEST-WARD
3.8.1 Company Information
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 MAJOR APPLICATION
4.1 Heparin-induced thrombocytopenia (HIT)
4.1.1 Overview
4.1.2 Heparin-induced thrombocytopenia (HIT) Market Size and Forecast
4.2 Percutaneous Coronary Intervention
4.2.1 Overview
4.2.2 Percutaneous Coronary Intervention Market Size and Forecast
4.3 Cerebral arterial thrombosis
4.3.1 Overview
4.3.2 Cerebral arterial thrombosis Market Size and Forecast
5 MARKET BY TYPE BY ARGATROBAN POWDER
5.1 Argatroban Powder
5.1.1 Overview
5.1.2 Argatroban Powder Market Size and Forecast
5.2 Argatroban Injection
5.2.1 Overview
5.2.2 Argatroban Injection Market Size and Forecast
6 PRICE OVERVIEW
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 CONCLUSION
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 Pfizer
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 SANDOZ
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 GlaxoSmithKline
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 fresenius-kabi
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4.4 Recent Development
3.5 Eagle Pharmaceuticals
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5.4 Recent Development
3.6 Mitsubishi Tanabe Pharma
3.6.1 Company Information
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6.4 Recent Development
3.7 Teva Pharmaceutical Industries
3.7.1 Company Information
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 WEST-WARD
3.8.1 Company Information
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 MAJOR APPLICATION
4.1 Heparin-induced thrombocytopenia (HIT)
4.1.1 Overview
4.1.2 Heparin-induced thrombocytopenia (HIT) Market Size and Forecast
4.2 Percutaneous Coronary Intervention
4.2.1 Overview
4.2.2 Percutaneous Coronary Intervention Market Size and Forecast
4.3 Cerebral arterial thrombosis
4.3.1 Overview
4.3.2 Cerebral arterial thrombosis Market Size and Forecast
5 MARKET BY TYPE BY ARGATROBAN POWDER
5.1 Argatroban Powder
5.1.1 Overview
5.1.2 Argatroban Powder Market Size and Forecast
5.2 Argatroban Injection
5.2.1 Overview
5.2.2 Argatroban Injection Market Size and Forecast
6 PRICE OVERVIEW
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 CONCLUSION
LIST OF TABLES
Tab Regional Production 2013-2018 (Million USD)
Tab Regional Production 2013-2018 (Volume)
Tab Regional Demand and CAGR 2013-2018 (Million USD)
Tab Regional Demand and CAGR 2013-2018 (Volume)
Tab Regional Demand Forecast and CAGR 2019-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2019-2025 (Volume)
Tab Regional Export 2013-2018 (Million USD)
Tab Regional Export 2013-2018 (Volume)
Tab Regional Import 2013-2018 (Million USD)
Tab Regional Import 2013-2018 (Volume)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of SANDOZ
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of GlaxoSmithKline
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of fresenius-kabi
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Eagle Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Mitsubishi Tanabe Pharma
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Teva Pharmaceutical Industries
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of WEST-WARD
Tab Regional Production 2013-2018 (Million USD)
Tab Regional Production 2013-2018 (Volume)
Tab Regional Demand and CAGR 2013-2018 (Million USD)
Tab Regional Demand and CAGR 2013-2018 (Volume)
Tab Regional Demand Forecast and CAGR 2019-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2019-2025 (Volume)
Tab Regional Export 2013-2018 (Million USD)
Tab Regional Export 2013-2018 (Volume)
Tab Regional Import 2013-2018 (Million USD)
Tab Regional Import 2013-2018 (Volume)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of SANDOZ
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of GlaxoSmithKline
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of fresenius-kabi
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Eagle Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Mitsubishi Tanabe Pharma
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Teva Pharmaceutical Industries
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of WEST-WARD
LIST OF FIGURES
Fig Global Argatroban Market Size and CAGR 2013-2018 (Million USD)
Fig Global Argatroban Market Size and CAGR 2013-2018 (Volume)
Fig Global Argatroban Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global Argatroban Market Forecast and CAGR 2019-2025 (Volume)
Fig Heparin-induced thrombocytopenia (HIT) Market Size and CAGR 2013-2018 (Million USD)
Fig Heparin-induced thrombocytopenia (HIT) Market Size and CAGR 2013-2018 (Volume)
Fig Heparin-induced thrombocytopenia (HIT) Market Forecast and CAGR 2019-2025 (Million USD)
Fig Heparin-induced thrombocytopenia (HIT) Market Forecast and CAGR 2019-2025 (Volume)
Fig Percutaneous Coronary Intervention Market Size and CAGR 2013-2018 (Million USD)
Fig Percutaneous Coronary Intervention Market Size and CAGR 2013-2018 (Volume)
Fig Percutaneous Coronary Intervention Market Forecast and CAGR 2019-2025 (Million USD)
Fig Percutaneous Coronary Intervention Market Forecast and CAGR 2019-2025 (Volume)
Fig Cerebral arterial thrombosis Market Size and CAGR 2013-2018 (Million USD)
Fig Cerebral arterial thrombosis Market Size and CAGR 2013-2018 (Volume)
Fig Cerebral arterial thrombosis Market Forecast and CAGR 2019-2025 (Million USD)
Fig Cerebral arterial thrombosis Market Forecast and CAGR 2019-2025 (Volume)
Fig Argatroban Powder Market Size and CAGR 2013-2018 (Million USD)
Fig Argatroban Powder Market Size and CAGR 2013-2018 (Volume)
Fig Argatroban Powder Market Forecast and CAGR 2019-2025 (Million USD)
Fig Argatroban Powder Market Forecast and CAGR 2019-2025 (Volume)
Fig Argatroban Injection Market Size and CAGR 2013-2018 (Million USD)
Fig Argatroban Injection Market Size and CAGR 2013-2018 (Volume)
Fig Argatroban Injection Market Forecast and CAGR 2019-2025 (Million USD)
Fig Argatroban Injection Market Forecast and CAGR 2019-2025 (Volume)
Fig Global Argatroban Market Size and CAGR 2013-2018 (Million USD)
Fig Global Argatroban Market Size and CAGR 2013-2018 (Volume)
Fig Global Argatroban Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global Argatroban Market Forecast and CAGR 2019-2025 (Volume)
Fig Heparin-induced thrombocytopenia (HIT) Market Size and CAGR 2013-2018 (Million USD)
Fig Heparin-induced thrombocytopenia (HIT) Market Size and CAGR 2013-2018 (Volume)
Fig Heparin-induced thrombocytopenia (HIT) Market Forecast and CAGR 2019-2025 (Million USD)
Fig Heparin-induced thrombocytopenia (HIT) Market Forecast and CAGR 2019-2025 (Volume)
Fig Percutaneous Coronary Intervention Market Size and CAGR 2013-2018 (Million USD)
Fig Percutaneous Coronary Intervention Market Size and CAGR 2013-2018 (Volume)
Fig Percutaneous Coronary Intervention Market Forecast and CAGR 2019-2025 (Million USD)
Fig Percutaneous Coronary Intervention Market Forecast and CAGR 2019-2025 (Volume)
Fig Cerebral arterial thrombosis Market Size and CAGR 2013-2018 (Million USD)
Fig Cerebral arterial thrombosis Market Size and CAGR 2013-2018 (Volume)
Fig Cerebral arterial thrombosis Market Forecast and CAGR 2019-2025 (Million USD)
Fig Cerebral arterial thrombosis Market Forecast and CAGR 2019-2025 (Volume)
Fig Argatroban Powder Market Size and CAGR 2013-2018 (Million USD)
Fig Argatroban Powder Market Size and CAGR 2013-2018 (Volume)
Fig Argatroban Powder Market Forecast and CAGR 2019-2025 (Million USD)
Fig Argatroban Powder Market Forecast and CAGR 2019-2025 (Volume)
Fig Argatroban Injection Market Size and CAGR 2013-2018 (Million USD)
Fig Argatroban Injection Market Size and CAGR 2013-2018 (Volume)
Fig Argatroban Injection Market Forecast and CAGR 2019-2025 (Million USD)
Fig Argatroban Injection Market Forecast and CAGR 2019-2025 (Volume)
